Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

NCT01365494 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Vaccines